Genomic profiling in CEPH cell lines distinguishes between the camptothecins and indenoisoquinolines

Molecular Cancer Therapeutics

Volumn 10, Issue 10, 2011, Pages 1839-1845

  Watson, Venita Gresham ^a   Hardison, Nicholas E ^b   Harris, Tyndall ^b   Motsinger Reif, Alison ^b   McLeod, Howard L ^a  

^a University of North Carolina   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; INDENOISOQUINOLINE 1; INDENOISOQUINOLINE 2; INDENOISOQUINOLINE 3; NCS 725776; NSC 70644; NSC 724998; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 16; CYTOTOXICITY; DNA FINGERPRINTING; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LINKAGE ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SENSITIVITY ANALYSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; ISOQUINOLINES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUANTITATIVE TRAIT LOCI; TOPOISOMERASE I INHIBITORS;

EID: 80053960665     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0872     Document Type: Article

References (24)

1. Jung LL, Zamboni WC. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it? Drug Resist Updat 2001;4:273-88.
2. Antony S, Agama KK, Miao ZH, Takagi K, Wright MH, Robles AI, et al. Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance. Cancer Res 2007;67:10397-405. (Pubitemid 350070815)
3. Antony S, Jayaraman M, Laco G, Kohlhagen G, Kohn KW, Cushman M, et al. Differential Induction of Topoisomerase I-DNA Cleavage Complexes by the Indenoisoquinoline MJ-III-65 (NSC 706744) and Camptothecin: Base Sequence Analysis and Activity against Camptothecin-Resistant Topoisomerases I. Cancer Res 2003;63:7428-35. (Pubitemid 37413485)
4. Pommier Y, Cushman M. The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives. Mol Cancer Ther 2009;8:1008-14.
5. Staker BL, Feese MD, Cushman M, Pommier Y, Zembower D, Stewart L, et al. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. J Med Chem 2005;48:2336-45. (Pubitemid 40516428)
6. Antony S, Kohlhagen G, Agama K, Jayaraman M, Cao S, Durrani FA, et al. Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison. Mol Pharmacol 2005;67:523-30. (Pubitemid 40216745)
7. Shimoyama T, Hamano T, Natsume T, Koizumi F, Kiura K, Tanimoto M, et al. Reference profiling of the genomic response induced by an antimicrotubule agent, TZT-1027 (Soblidotin), in vitro. Pharmacogenomics J 2006;6:388-96. (Pubitemid 44811534)
8. Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, et al. Gene Expression Analysis Reveals Chemical-Specific Profiles. Toxicol Sci 2002;67:219-31. (Pubitemid 34746475)
9. Watson VG, Motsinger-Reif A, Hardison NE, Peters EJ, Havener TM, Everitt L, et al. Identification and Replication of Loci Involved in Camptothecin-Induced Cytotoxicity Using CEPH Pedigrees. PLoS One 2011;6:e17561.
10. Dausset J, Cann H, Cohen D, Lathrop M, Lalouel JM, White R. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 1990;6:575-7. (Pubitemid 20168693)
11. Dolan ME, Newbold KG, Nagasubramanian R, Wu X, Ratain MJ, Cook EH Jr., et al. Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity. Cancer Res 2004;64:4353-6. (Pubitemid 38802443)
12. Watters JW, Kraja A, Meucci MA, Province MA, McLeod HL. Genome-wide discovery of loci influencing chemotherapy cytotoxicity. Proc Natl Acad Sci U S A 2004;101:11809-14. (Pubitemid 39095376)
13. Coriell. National Institutes for General Medicine (NIGMS) Human Genetic Cell Repository: CEPH Reference Families. [cited 2010 March 11]. Available from: http://ccr.coriell.org/sections/collections/NIGMS/CEPHFamilies.aspx?PgId= 49&coll=GM.
14. Cohen D, Chumakov I, Weissenbach J. A first-generation physical map of the human genome. Nature 1993;366:698-701. (Pubitemid 24036019)
15. The Foundation Jean Dausset-Centre d'Etude du Polymorphisme Humain (CEPH) Genotyping Database Version 10. [cited 2010 March 11]. Available from: ftp://ftp.cephb.fr/ceph-genotype-db/ceph-db/Ver-10/mkr.
16. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL. Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 1998;63:861-9. (Pubitemid 30422687)
17. National Heart L, and Blood Institute and the Mammalian Genotyping Service (MGS) at Marshfield. CEPH Family Genotyping Data. [cited 2010 March 11]. Available from: http://research.marshfieldclinic.org/genetics/home/index.asp.
18. Medland SE, Schmitt JE, Webb BT, Kuo PH, Neale MC. Efficient calculation of empirical P-values for genome-wide linkage analysis through weighted permutation. Behav Genet 2009;39:91-100.
19. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101.
20. Jung J, Weeks DE, Feingold E. Gene-dropping vs. empirical variance estimation for allele-sharing linkage statistics. Genet Epidemiol 2006;30:652-65. (Pubitemid 44851513)
21. Fullerton JM, Donald JA, Mitchell PB, Schofield PR. Two-dimensional genome scan identifies multiple genetic interactions in bipolar affective disorder. Biol Psychiatry 2010;67:478-86.
22. Wojciechowski R, Moy C, Ciner E, Ibay G, Reider L, Bailey-Wilson JE, et al. Genomewide scan in Ashkenazi Jewish families demonstrates evidence of linkage of ocular refraction to a QTL on chromosome 1p36. Hum Genet 2006;119:389-99.
23. Stark AL, Zhang W, Mi S, Duan S, O'Donnell PH, Huang RS, et al. Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines. Pharmacogenomics J 2010;10:505-12.
24. Miao ZH, Player A, Shankavaram U, Wang YH, Zimonjic DB, Lorenzi PL, et al. Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses. Cancer Res 2007;67:8752-61. (Pubitemid 47437451)